Therapeutic process for inhibiting NF-κB

Details Therapeutic process for inhibiting NF-κB Therapeutic process for inhibiting NF-κB

2005-08-02

2005-08-02

Wilson, James O. (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

C514S534000, C514S575000, C514S617000

Reexamination Certificate

active

06924308

ABSTRACT:
A therapeutic process is provided for the inhibition of NF-κB in mammals in whose cells NF-κB has been activated by an agency external to said cell.

REFERENCES:
patent: 4252322 (1981-02-01), Orter
patent: 4263322 (1981-04-01), van't Riet et al.
patent: 4394389 (1983-07-01), van't Riet et al.
patent: 4448730 (1984-05-01), van't Riet et al.
patent: 4623659 (1986-11-01), van't Riet et al.
patent: 5183828 (1993-02-01), van't Riet et al.
patent: 5350770 (1994-09-01), Elford et al.
patent: 5366996 (1994-11-01), Elford et al.
Casarett and Doull's Toxicology: The Basic Science of Poison, C.D. Klaassen, ed.; McGraw-Hill 1996, pp. 42.
Salvemini et al 286 Science 304 (Oct. 1999).
Jenney et al 286 Science 906 (Oct. 1999).
Hogness & Johnson Qualitative Analysis and Chemical Equilibrium pp. 247-253, Henry Holt and Co., New York (1940).
Kharasch, Rowe and Urry J. Org. Chem 1951 pp. 905-913.
Meyer et al EMBO J. 12 2005 (1993).
Staal et al Methods Enzymol 252 168 ((1995).
M. Barinaga “Life-Death Balance Within the Cell” Science 274, Nov. 1, 1996.
Roederer et al Proc. Nat. Acad. Sci. 87 4884 (Jun. 1990).
Barnes et al New England Journal of Medicine 336 1066 (1997).
Staal et al AIDS Research and Human Retroviruses 9 299 (1993).
Beg & Baltimore Science 274 782 (Nov. 1996).
Baruchel et al J. Leuko. Biol. 52 111 (Jul. 1992).
Hauser et al Can. Res. 50 3503 (Jun. 1990).
Green Science 274 1246 (Nov. 1997).
Kumar et al Science 278 1630 (Nov. 1997).
M. Barinaga Science 280 32 (Apr. 1998).
Baeuerle et al Ann. Rev. Immun. 12 141 (1994).

Affiliated with

Also associated with

Rating

Therapeutic process for inhibiting NF-κB does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic process for inhibiting NF-κB, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic process for inhibiting NF-κB will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3511572